ARMISTICE CAPITAL LLC 13D and 13G filings for Protagenic Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:06 pm Unchanged |
2024-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX |
ARMISTICE CAPITAL LLC | 240,000 3.410% |
0 (Unchanged) |
Filing |
| 2024-11-14 5:19 pm Unchanged |
2024-09-30 | 13G | Protagenic Therapeutics, Inc. PTIX |
ARMISTICE CAPITAL LLC | 240,000 5.100% |
0 (Unchanged) |
Filing |
| 2024-02-14 2:29 pm Purchase |
2023-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX |
ARMISTICE CAPITAL LLC | 240,000 5.130% |
240,000 (New Position) |
Filing |